Global pharmaceutical company Allergan has confirmed that it has received Food and Drug Administration (FDA) approval to market JUVÉDERM VOLLURE XC for the correction of moderate to severe facial wrinkles and folds in the US.
Hyaluronic acid dermal filler Restylane Kysse, produced by global pharmaceutical company Galderma, received high subject and partner satisfaction, according to new phase 4 study results.
Pharmaceutical company Galderma hosted their Inaugural GAIN (Galderma Aesthetic Injector Network) event in Geneva, Switzerland, highlighting what transformational aesthetic journeys look like for different patients.
Pharmaceutical company Galderma is discontinuing the Restylane Fynesse dermal filler from the Optimal Balance Technology (OBT) range.
Dermatology company Galderma has announced that its hyaluronic acid dermal filler Restylane Silk has received approval by the US Food and Drug Administration (FDA) for lip augmentation with the use of a small blunt tip cannula.
Discover the ultimate 3D facial profiling technique with Restylane Lyft, Volyme and Defyne
Two of the industry’s leading companies could become one if a multi-million dollar bid by Galderma to acquire Q-Med goes ahead. In a joint venture between L’Oreal and Nestle. Galderma, the makers of Azzalure®, launched a reported $970 million bid for the Swedish manufacturer of Restylane® at the end of 2010.
Global aesthetic manufacturer Teoxane Laboratories has announced that the US Food and Drug Administration (FDA) has approved three of its dermal fillers.
Belotero Balance hyaluronic acid (HA) dermal filler from pharmaceutical company Merz Aesthetics has received US Food and Drug Administration (FDA) approval for under-eye treatments.
Pharmaceutical company Galderma has launched hyaluronic acid filler Restylane Eyelight to the UK.